Literature DB >> 35762438

[Progressive psychomotor regression for 2.5 years in a boy aged 5 years].

Mao-Qiang Tian, Xiao-Xi Chen1, Lei Li, Chang-Hui Lang, Juan Li, Jing Chen, Xiao-Hua Yu, Xiao-Mei Shu.   

Abstract

A boy, aged 5 years, attended the hospital due to progressive psychomotor regression for 2.5 years. Motor function regression was the main manifestation in the early stage, and brain MRI and whole-exome sequencing (WES) of the family showed no abnormalities. After the age of 4 years and 9 months, the boy developed cognitive function regression, and brain MRI showed cerebellar atrophy. The reanalysis of WES results revealed a compound heterozygous mutation, [NM_000520, c.784C>T(p.His262Tyr]), c.1412C>T(p.Pro471Leu)], in the HEXA gene. The enzyme activity detection showed a significant reduction in the level of β-hexosaminidase encoded by this gene. The boy was diagnosed with juvenile Tay-Sachs disease (TSD). TSD has strong clinical heterogeneity, and cerebellar atrophy may be an important clue for the diagnosis of juvenile TSD. The reanalysis of genetic data when appropriate based on disease evolution may improve the positive rate of WES.

Entities:  

Keywords:  Cerebellar atrophy; Child; Gangliosidosis; HEXA gene; Tay-Sachs disease

Mesh:

Year:  2022        PMID: 35762438      PMCID: PMC9250405          DOI: 10.7499/j.issn.1008-8830.2201048

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  19 in total

1.  Direct Intracranial Injection of AAVrh8 Encoding Monkey β-N-Acetylhexosaminidase Causes Neurotoxicity in the Primate Brain.

Authors:  Diane Golebiowski; Imramsjah M J van der Bom; Churl-Su Kwon; Andrew D Miller; Keiko Petrosky; Allison M Bradbury; Stacy Maitland; Anna Luisa Kühn; Nina Bishop; Elizabeth Curran; Nilsa Silva; Dwijit GuhaSarkar; Susan V Westmoreland; Douglas R Martin; Matthew J Gounis; Wael F Asaad; Miguel Sena-Esteves
Journal:  Hum Gene Ther       Date:  2017-01-26       Impact factor: 5.695

2.  Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation.

Authors:  R Wada; C J Tifft; R L Proia
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

3.  Reanalysis of whole exome sequencing data in patients with epilepsy and intellectual disability/mental retardation.

Authors:  Jinliang Li; Kai Gao; Huifang Yan; Wenshu Xiangwei; Nana Liu; Tianshuang Wang; Han Xu; Zehong Lin; Han Xie; Jingmin Wang; Ye Wu; Yuwu Jiang
Journal:  Gene       Date:  2019-03-21       Impact factor: 3.688

4.  Pontocerebellar atrophy is the hallmark neuroradiological finding in late-onset Tay-Sachs disease.

Authors:  Jitka Májovská; Anita Hennig; Igor Nestrasil; Susanne A Schneider; Helena Jahnová; Manuela Vaněčková; Martin Magner; Petr Dušek
Journal:  Neurol Sci       Date:  2021-11-20       Impact factor: 3.830

5.  Haematopoietic Stem Cell Transplantation Arrests the Progression of Neurodegenerative Disease in Late-Onset Tay-Sachs Disease.

Authors:  Karolina M Stepien; Su Han Lum; J Edmond Wraith; Christian J Hendriksz; Heather J Church; David Priestman; Frances M Platt; Simon Jones; Ana Jovanovic; Robert Wynn
Journal:  JIMD Rep       Date:  2017-12-07

6.  Mitochondrial PITRM1 peptidase loss-of-function in childhood cerebellar atrophy.

Authors:  Yeshaya Langer; Adi Aran; Suleyman Gulsuner; Bassam Abu Libdeh; Paul Renbaum; Dario Brunetti; Pedro-Filipe Teixeira; Tom Walsh; Sharon Zeligson; Roberta Ruotolo; Rachel Beeri; Imad Dweikat; Maher Shahrour; Ariella Weinberg-Shukron; Fouad Zahdeh; Enrico Baruffini; Elzbieta Glaser; Mary-Claire King; Ephrat Levy-Lahad; Massimo Zeviani; Reeval Segel
Journal:  J Med Genet       Date:  2018-05-15       Impact factor: 6.318

7.  Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort.

Authors:  Anne Rochtus; Heather E Olson; Lacey Smith; Louisa G Keith; Christelle El Achkar; Alan Taylor; Sonal Mahida; Meredith Park; McKenna Kelly; Catherine Shain; Shira Rockowitz; Beth Rosen Sheidley; Annapurna Poduri
Journal:  Epilepsia       Date:  2020-01-19       Impact factor: 5.864

8.  Substrate Reduction Therapy for Sandhoff Disease through Inhibition of Glucosylceramide Synthase Activity.

Authors:  John Marshall; Jennifer B Nietupski; Hyejung Park; James Cao; Dinesh S Bangari; Cristina Silvescu; Terry Wilper; Kristen Randall; Drew Tietz; Bing Wang; Xiaoyou Ying; John P Leonard; Seng H Cheng
Journal:  Mol Ther       Date:  2019-06-04       Impact factor: 11.454

9.  Functionality of a bicistronic construction containing HEXA and HEXB genes encoding β-hexosaminidase A for cell-mediated therapy of GM2 gangliosidoses.

Authors:  Alisa A Shaimardanova; Daria S Chulpanova; Valeriya V Solovyeva; Aleksandr M Aimaletdinov; Albert A Rizvanov
Journal:  Neural Regen Res       Date:  2022-01       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.